Gene expression profile may ID renal cell carcinoma pts unlikely to benefit from nivolumab
Renal cell carcinomas positive for the protein PD-L1 from patients who did not respond to treatment with the anti-PD-1 therapeutic nivolumab (Opdivo) had significantly higher expression of genes associated with metabolism, ...
Aug 4, 2016
